Organization · Venture Capital
Clinical Research Ventures
Clinical Research Ventures is a specialty life-science investor focused on funding Phase I and II clinical trials for biotech and medtech companies. With a unique investment structure, it aims to provide more control and less dilution for its portfolio companies.
Overview
What Clinical Research Ventures does
What Clinical Research Ventures is
Clinical Research Ventures is a specialty life-science investor focused on funding Phase I and II clinical trials for biotech and medtech companies. With a unique investment structure, it aims to provide more control and less dilution for its portfolio companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Clinical Research Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Clinical Research Ventures as a funder
Investment thesis
Clinical Research Ventures focuses on funding Phase I and Phase II clinical trials in the life sciences sector, providing an alternative to traditional equity rounds for biotech and medtech companies.
Focus narrative
CR Ventures invests exclusively in companies conducting clinical trials in the life sciences sector. By partnering with clinical research organizations, the firm facilitates rapid start-up, enrollment, and successful trial completion for its portfolio companies, ensuring they have the necessary resources to advance their clinical programs.
Value beyond capital
Clinical Research Ventures offers a distinctive value proposition by providing funding specifically for clinical trials, allowing portfolio companies to maintain more control and experience less dilution. This model accelerates clinical progress and serves as an alternative to raising traditional equity rounds solely for trial funding.
Terms and economics
- Typical check
- $50,000,000
Focus and fit
- Stages
- Series A · Series B
- Regions
- Global · North America · Europe · Asia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 4
Portfolio context
Notable portfolio companies include: Astrocyte Pharmaceuticals, Inc.: Focuses on traumatic brain injury, stroke, and concussion. BioVersys AG: Works on multi-drug resistant bacterial infections. Xeno Biosciences Inc.: Addresses obesity and related diseases. Adiposs SA: Concentrates on the early detection of cancer cachexia.
Common questions
What to know about Clinical Research Ventures
Upseed classifies Clinical Research Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.